Effectiveness and safety of elbasvir/grazoprevir in Korean patients with hepatitis C virus infection: a nationwide real-world study
Eun Sun Jang, Kyung-Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook-Hyang Jeong
Korean J Intern Med. 2021;36(Suppl 1):S1-S8. Published online 2020 Jun 17 DOI: https://doi.org/10.3904/kjim.2019.357
Citations to this article as recorded by 
Antibodies directed against bacterial antigens in sera of Polish patients with primary biliary cholangitis
Alicja Bauer, Andrzej Habior
Frontiers in Cellular and Infection Microbiology.2025;[Epub] CrossRef
The impact of hospital surge capacity during the 2009 influenza pandemic on patient safety: A systematic review
Inge Dhamanti, Auliya Abdurrohim Suwantika, Nur Atika, Benny Tjahjono
International Journal of Healthcare Management.2024; : 1. CrossRef
A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD
Ethan M. Balk, Gaelen P. Adam, Michel Jadoul, Paul Martin, Craig E. Gordon
Kidney International Reports.2023; 8(2): 240. CrossRef
Elbasvir/grazoprevir
Reactions Weekly.2023; 1938(1): 583. CrossRef
A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
Hye-Lin Kim, Kyung-Ah Kim, Gwang Hyun Choi, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook-Hyang Jeong
Clinical and Molecular Hepatology.2022; 28(1): 91. CrossRef